Matthew Ross Boyd - 08 Jul 2025 Form 3 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Regulatory Officer
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Issuer symbol
ENGN
Transactions as of
08 Jul 2025
Net transactions value
$0
Form type
3
Filing time
14 Jul 2025, 16:09:12 UTC
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boyd Matthew Ross Chief Regulatory Officer C/O 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, QUEBEC, CANADA /s/ Lee Giguere, as attorney-in-fact for the Reporting Person 14 Jul 2025 0002077001

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENGN Common Shares 7,500 08 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENGN Stock Option (Right to Buy) 08 Jul 2025 Common Shares 68,000 $6.60 Direct F1
holding ENGN Stock Option (Right to Buy) 08 Jul 2025 Common Shares 51,000 $7.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on September 16, 2025, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the next three years, subject to the reporting person's continued service.
F2 This option vests in equal monthly installments over forty-eight (48) months on the last day of each month commencing January 29, 2025, subject to the reporting person's continued service.

Remarks:

Exhibit 24 - Power of Attorney